The onychomycosis ICD 10 code is B35.1, tinea unguium. The nail fungus ICD 10 code is the same B35.1 and the procedure codes are CPT 11720 for debridement of 1 to 5 nails and CPT 11721 for 6 or more. The important thing to state here is that Medicare treats nail debridement as routine foot care and excludes it. So, the claim pays when the note shows a systemic condition with class findings, or a fungal nail that is painful, infected, or limiting walking.
What is Onychomycosis?
It is a fungal infection of the nail plate and the nail bed. It is more often found in the toenails rather than fingernails. Dermatophytes are the most common cause of this problem. Yeasts such as Candida and some molds cause it too. This is the reason why B35.1 and B37.2 are separate codes. It appears as thickening, yellow-white or brown discoloration, brittle or crumbling edge, debris under the nail. Sometimes the nail lifts from the bed and the condition is called onycholysis. Those visible signs are what a MAC means by “clinical evidence of mycosis,” so the note that describes them is doing coverage work, not only clinical work. Psoriasis and nail trauma can look the same, so a fungal culture is how the two are told apart.
Onychomycosis ICD-10: B35.1 and the Codes Around It
Understanding that B35.1 is one code for every dermatophyte nail infection is important: any nail, any number, and either side. The formal name of this code is tinea unguium. The tabular lists “onychomycosis” and “ringworm of nails” as inclusion terms, and “fungal nail infection” is the everyday name, so all these terms land on the same code. Here are some codes, descriptors, and when they are used:
| Code | Descriptor | When |
|---|---|---|
| B35.1 | Tinea unguium | Dermatophyte onychomycosis, any nail, either side |
| B37.2 | Candidiasis of skin and nail | Candida onychomycosis |
| B35.3 / B35.2 | Tinea pedis / Tinea manuum | Coexisting skin infection, when documented |
| L60.2 | Onychogryphosis | Thick, claw-like nail, non-fungal |
| L60.3 | Nail dystrophy | Deformed nail, non-fungal |
| M79.674 / M79.675 | Pain in right / left toe(s) | Carries the side and the pain criterion (laterality lives here, not B35.1) |
CPT 11720 vs CPT 11721: Debridement or Trimming
There is a need to differentiate between debridement and trimming. So, let’s understand these concepts first. Debridement of a nail is cutting down or grinding a thick and diseased nail to reduce its thickness and length. The nail is abnormal and the work reduces it. Trimming a nail is cutting the free edge. If the nail is normal, it is 11719 which is trimming of nondystrophic nails, any number. In a case where the nail is thick and all that was performed was clipping, it is G0127, which is a Medicare HCPCS code.
| Code | What | Count | 2026 office payment, national, before geographic adjustment |
|---|---|---|---|
| 11719 | Trimming of nondystrophic nails | Any number | ≈ $14.36 |
| G0127 | Trimming of dystrophic nails | Any number | Medicare-specific HCPCS code |
| 11720 | Debridement of nail(s), any method | 1 to 5 | ≈ $32.73 |
| 11721 | Debridement of nail(s), any method | 6 or more | ≈ $45.09 |
Why Medicare Excludes Routine Foot Care
This is where we discuss something very specific. Medicare rulebook, the Benefit Policy Manual, Chapter 15, section 290, says routine foot care is not a covered benefit. The definition of routine foot care mentions the nail work directly: trimming, cutting, clipping, or debriding of nails. So, 11720 and 11721 are the services Medicare does not pay, by default.
A denial for lack of medical necessity for nail care is a judgment on one patient. And “excluded” is a rule about the service. As this is a routine foot care exclusion, the patient can be billed when no exception applies. What should the paperwork entail for a Medicare patient? An Advance Beneficiary Notice (ABN) signed before the service if the patient wants the nails done anyway.
When Mycotic Nails Qualify: B35.1 With a Pain Code
There are two scenarios here: Scenario A is for the patients with a disease that makes foot care dangerous in the hands of untrained caregivers. Scenario B is for the patient whose fungal nails hurt, are infected, or stop them walking properly. Scenario A requires systemic conditions (at-risk foot care with a Q7/Q8/Q9 modifier) that lead to foot damage. Scenario B requires no systemic conditions. It is related to mycotic nails and the note shows clinical evidence of mycosis. No Q modifiers are required for this scenario.
It is important to discuss here what NGS, the Medicare contractor for several northeastern and midwestern states, says in its foot care article about mycotic nails. “Ambulatory patient must have marked limitation of ambulation, pain, or secondary infection resulting from the thickening and dystrophy of infected toenail plate. Non-ambulatory patient suffers from pain or secondary infection resulting from the thickening and dystrophy of infected toenail plate.” How the coding is done: B35.1 first, then the code that proves the problem: M79.674 / M79.675 for pain (and it supplies the side), L03.03- cellulitis of toe for secondary infection, R26.2 difficulty walking for limited ambulation.
Comorbidity Codes That Support the Claim
To understand this section, keep the scenarios discussed in the previous section in mind. Scenario A is based on the systemic condition code, so the comorbidities need specific codes. E11.x is type 2 diabetes. The characters after the dot show the name of the complication. E11.40 is neuropathy unspecified. E11.42 is polyneuropathy. E11.51 is peripheral angiopathy without gangrene. E11.621 is a foot ulcer, and E11.9 shows no complications.
I73.9 is peripheral vascular disease, unspecified. It is related to a poor blood flow to the legs. L97.5xx is a non-pressure chronic ulcer of the other part of the foot. The 5th character in the code shows the side, L97.51 for the right, and L97.52 for the left. The 6th character is depth. For L97, any associated underlying condition is coded first. With diabetes, it is E11.621 first, then L97.5xx. An open ulcer on the treated foot shows a strong evidence that non-professional nail care can be dangerous.
Fungal Culture: When It Is Needed
There is a common notion that lab tests are required before Medicare pays for debridement. This is not the rule. The MAC criterion is the clinical evidence of mycosis, which is seen by the clinician. There are two jobs that the lab performs and NGS says what they are. KOH prep (87220) is a nail scraping dissolved in potassium hydroxide and a microscope is used to look for the presence of fungal elements. The other one is fungal culture (87101) in which the scraping is grown on a plate for weeks to identify the organism. Both are billed by the one who runs the lab, these are not part of the 11720/11721. NGS puts it this way: “Routine identification of fungi…is medically indicated only when necessary to differentiate fungal disease from psoriatic nail, or when definitive treatment for prolonged oral antifungal therapy has been planned.”
For commercial payers, the reimbursement rules vary by payer. Some require confirmation before covering oral antifungal drugs. There is a negative culture coding risk: if the test says negative with “onychomycosis” in the note. The code is B35.1 only when the clinical evidence supports it. Otherwise, it is L60.2 / L60.3.
Documentation and Denials
Here is a checklist that can help maintain accurate documentation:
- Which nails are affected and how many
- Each nail should be described: thickened, discolored, dystrophic
- Method: burr, grinder, nipper
- Class findings itemized on the treated foot in scenario A. For scenario B, pain or secondary infection or limited ambulation stated with the nails
- Systemic condition, MD/DO date last seen and NPI when it is needed
- The NGS sentence: what, how, where, correlated to the exam
- Signature and date
- Accurate modifiers should be there: modifier 25 on a same-day E/M only if it is a separate problem. 59/XS only for a separate procedure at a separate site.
| What happened | Remit | Root cause |
|---|---|---|
| 11721 with B35.1 only | CO-50 | No pain/infection code and no systemic pathway; the exclusion applies |
| E11.9 + B35.1, no Q modifier | CO-4 / CO-50 | Scenario A claimed without class findings or modifier |
| 11720 and 11721 on the same date | Second line denied | One code covers the count |
| B35.1 coded; note says “thick nails,” no mycosis evidence | Audit finding | Should be L60.2 / L60.3 |
| Diabetes pathway, no date last seen / NPI | Returned or denied | Active-care requirement |
Podiatry claims fail on the exception, not the code, and checking which scenario the note opens before the claim goes out is the work of a podiatry billing services team. Maintain accurate documentation, reduce denials, and streamline reimbursements for your podiatry practice.
